<author><surname>Porter</surname> <given-names>PL</given-names> </author><title>Global trends in breast cancer incidence and mortality</title><source>Salud P&#250;blica M&#233;x</source><year>2009</year><volume>51</volume><issue>Suppl 2</issue><fpage>s141</fpage><lpage>s146</lpage>
<author><surname>Travis</surname> <given-names>RC</given-names> </author><author><surname>Reeves</surname> <given-names>GK</given-names> </author><author><surname>Green</surname> <given-names>J</given-names> </author><title>Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study</title><source>Lancet</source><year>2010</year><volume>375</volume><issue>9732</issue><fpage>2143</fpage><lpage>2151</lpage>
<author><surname>Buck</surname> <given-names>MB</given-names> </author><author><surname>Knabbe</surname> <given-names>C</given-names> </author><title>TGF-&#946; signaling in breast cancer</title><source>Ann NY Acad Sci</source><year>2006</year><volume>1089</volume><fpage>119</fpage><lpage>126</lpage>
<author><surname>Dijke</surname> <given-names>P</given-names> </author><author><surname>Hill</surname> <given-names>CS</given-names> </author><title>New insights into TGF-&#946;-Smad signalling</title><source>Trends Biochem Sci</source><year>2004</year><volume>29</volume><issue>5</issue><fpage>265</fpage><lpage>273</lpage>
<author><surname>Moustakas</surname> <given-names>A</given-names> </author><author><surname>Heldin</surname> <given-names>CH</given-names> </author><title>Non-Smad TGF-&#946; signals</title><source>J Cell Sci</source><year>2005</year><volume>118</volume><issue>Pt 16</issue><fpage>3573</fpage><lpage>3584</lpage>
<author><surname>Zhang</surname> <given-names>YE</given-names> </author><title>Non-Smad pathways in TGF-&#946; signaling</title><source>Cell Res</source><year>2009</year><volume>19</volume><issue>1</issue><fpage>128</fpage><lpage>139</lpage>
<author><surname>Lee</surname> <given-names>MK</given-names> </author><author><surname>Pardoux</surname> <given-names>C</given-names> </author><author><surname>Hall</surname> <given-names>MC</given-names> </author><title>TGF-&#946; activates Erk MAP kinase signalling through direct phosphorylation of ShcA</title><source>EMBO J</source><year>2007</year><volume>26</volume><issue>17</issue><fpage>3957</fpage><lpage>3967</lpage>
<author><surname>Bhowmick</surname> <given-names>NA</given-names> </author><author><surname>Zent</surname> <given-names>R</given-names> </author><author><surname>Ghiassi</surname> <given-names>M</given-names> </author><title>Integrin &#946; 1 signaling is necessary for transforming growth factor-&#946; activation of p38MAPK and epithelial plasticity</title><source>J Biol Chem</source><year>2001</year><volume>276</volume><issue>50</issue><fpage>46707</fpage><lpage>46713</lpage>
<author><surname>Edlund</surname> <given-names>S</given-names> </author><author><surname>Landstrom</surname> <given-names>M</given-names> </author><author><surname>Heldin</surname> <given-names>CH</given-names> </author><title>Transforming growth factor-&#946;-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA</title><source>Mol Biol Cell</source><year>2002</year><volume>13</volume><issue>3</issue><fpage>902</fpage><lpage>914</lpage>
<author><surname>Wilkes</surname> <given-names>MC</given-names> </author><author><surname>Murphy</surname> <given-names>SJ</given-names> </author><author><surname>Garamszegi</surname> <given-names>N</given-names> </author><title>Cell-type-specific activation of PAK2 by transforming growth factor &#946; independent of Smad2 and Smad3</title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><issue>23</issue><fpage>8878</fpage><lpage>8889</lpage>
<author><surname>Barcellos-Hoff</surname> <given-names>MH</given-names> </author><author><surname>Akhurst</surname> <given-names>RJ</given-names> </author><title>Transforming growth factor-&#946; in breast cancer: too much, too late</title><source>Breast Cancer Res</source><year>2009</year><volume>11</volume><issue>1</issue><fpage>202</fpage>
<author><surname>Kleuser</surname> <given-names>B</given-names> </author><author><surname>Malek</surname> <given-names>D</given-names> </author><author><surname>Gust</surname> <given-names>R</given-names> </author><title>17-&#946;-estradiol inhibits transforming growth factor-&#946; signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30</title><source>Mol Pharmacol</source><year>2008</year><volume>74</volume><issue>6</issue><fpage>1533</fpage><lpage>1543</lpage>
<author><surname>Hinshelwood</surname> <given-names>RA</given-names> </author><author><surname>Huschtscha</surname> <given-names>LI</given-names> </author><author><surname>Melki</surname> <given-names>J</given-names> </author><title>Concordant epigenetic silencing of transforming growth factor-&#946; signaling pathway genes occurs early in breast carcinogenesis</title><source>Cancer Res</source><year>2007</year><volume>67</volume><issue>24</issue><fpage>11517</fpage><lpage>11527</lpage>
<author><surname>Akhurst</surname> <given-names>RJ</given-names> </author><author><surname>Derynck</surname> <given-names>R</given-names> </author><title>TGF-&#946; signaling in cancer&#8211;a double-edged sword</title><source>Trends Cell Biol</source><year>2001</year><volume>11</volume><issue>11</issue><fpage>S44</fpage><lpage>S51</lpage>
<author><surname>Turashvili</surname> <given-names>G</given-names> </author><author><surname>Bouchal</surname> <given-names>J</given-names> </author><author><surname>Baumforth</surname> <given-names>K</given-names> </author><title>Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis</title><source>BMC Cancer</source><year>2007</year><volume>7</volume><fpage>55</fpage>
<author><surname>Figueroa</surname> <given-names>JD</given-names> </author><author><surname>Flanders</surname> <given-names>KC</given-names> </author><author><surname>Garcia-Closas</surname> <given-names>M</given-names> </author><title>Expression of TGF-&#946; signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics</title><source>Breast Cancer Res Treat</source><year>2010</year><volume>121</volume><issue>3</issue><fpage>727</fpage><lpage>735</lpage>
<author><surname>Xu</surname> <given-names>J</given-names> </author><author><surname>Lamouille</surname> <given-names>S</given-names> </author><author><surname>Derynck</surname> <given-names>R</given-names> </author><title>TGF-&#946;-induced epithelial to mesenchymal transition</title><source>Cell Res</source><year>2009</year><volume>19</volume><issue>2</issue><fpage>156</fpage><lpage>172</lpage>
<author><surname>Miyazono</surname> <given-names>K</given-names> </author><title>Transforming growth factor-&#946; signaling in epithelial-mesenchymal transition and progression of cancer</title><source>Proc Jpn Acad B Phys Biol Sci</source><year>2009</year><volume>85</volume><issue>8</issue><fpage>314</fpage><lpage>323</lpage>
<author><surname>Massagu&#233;</surname> <given-names>J</given-names> </author><title>TGF&#946; in cancer</title><source>Cell</source><year>2008</year><volume>134</volume><issue>2</issue><fpage>215</fpage><lpage>230</lpage>
<author><surname>Dijke</surname> <given-names>P</given-names> </author><author><surname>Goumans</surname> <given-names>MJ</given-names> </author><author><surname>Pardali</surname> <given-names>E</given-names> </author><title>Endoglin in angiogenesis and vascular diseases</title><source>Angiogenesis</source><year>2008</year><volume>11</volume><issue>1</issue><fpage>79</fpage><lpage>89</lpage>
<author><surname>Flavell</surname> <given-names>RA</given-names> </author><author><surname>Sanjabi</surname> <given-names>S</given-names> </author><author><surname>Wrzesinski</surname> <given-names>SH</given-names> </author><title>The polarization of immune cells in the tumour environment by TGF-&#946;. Nature reviews</title><source>Immunology</source><year>2010</year><volume>10</volume><issue>8</issue><fpage>554</fpage><lpage>567</lpage>
<author><surname>Buijs</surname> <given-names>JT</given-names> </author><author><surname>Henriquez</surname> <given-names>NV</given-names> </author><author><surname>Overveld</surname> <given-names>PG</given-names> </author><title>Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer</title><source>Cancer Res</source><year>2007</year><volume>67</volume><issue>18</issue><fpage>8742</fpage><lpage>8751</lpage>
<author><surname>Bos</surname> <given-names>PD</given-names> </author><author><surname>Nguyen</surname> <given-names>DX</given-names> </author><author><surname>Massagu&#233;</surname> <given-names>J</given-names> </author><title>Modeling metastasis in the mouse</title><source>Curr Opin Pharmacol</source><year>2010</year><volume>10</volume><issue>5</issue><fpage>571</fpage><lpage>577</lpage>
<author><surname>Tsuji</surname> <given-names>T</given-names> </author><author><surname>Ibaragi</surname> <given-names>S</given-names> </author><author><surname>Hu</surname> <given-names>GF</given-names> </author><title>Epithelial-mesenchymal transition and cell cooperativity in metastasis</title><source>Cancer Res</source><year>2009</year><volume>69</volume><issue>18</issue><fpage>7135</fpage><lpage>7139</lpage>
<author><surname>Grunert</surname> <given-names>S</given-names> </author><author><surname>Jechlinger</surname> <given-names>M</given-names> </author><author><surname>Beug</surname> <given-names>H</given-names> </author><title>Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nature reviews</title><source>Molec Cell Biol</source><year>2003</year><volume>4</volume><issue>8</issue><fpage>657</fpage><lpage>665</lpage>
<author><surname>Padua</surname> <given-names>D</given-names> </author><author><surname>Zhang</surname> <given-names>XH</given-names> </author><author><surname>Wang</surname> <given-names>Q</given-names> </author><title>TGF-&#946; primes breast tumors for lung metastasis seeding through angiopoietin-like 4</title><source>Cell</source><year>2008</year><volume>133</volume><issue>1</issue><fpage>66</fpage><lpage>77</lpage>
<author><surname>Godde</surname> <given-names>NJ</given-names> </author><author><surname>Galea</surname> <given-names>RC</given-names> </author><author><surname>Elsum</surname> <given-names>IA</given-names> </author><title>Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions</title><source>J Mammary Gland Biol Neoplasia</source><year>2010</year><volume>15</volume><issue>2</issue><fpage>149</fpage><lpage>168</lpage>
<author><surname>Zavadil</surname> <given-names>J</given-names> </author><author><surname>Bottinger</surname> <given-names>EP</given-names> </author><title>TGF-&#946; and epithelial-to-mesenchymal transitions</title><source>Oncogene</source><year>2005</year><volume>24</volume><issue>37</issue><fpage>5764</fpage><lpage>5774</lpage>
<author><surname>Miettinen</surname> <given-names>PJ</given-names> </author><author><surname>Ebner</surname> <given-names>R</given-names> </author><author><surname>Lopez</surname> <given-names>AR</given-names> </author><title>TGF-&#946; induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors</title><source>J Cell Biol</source><year>1994</year><volume>127</volume><issue>6 Pt 2</issue><fpage>2021</fpage><lpage>2036</lpage>
<author><surname>Piek</surname> <given-names>E</given-names> </author><author><surname>Moustakas</surname> <given-names>A</given-names> </author><author><surname>Kurisaki</surname> <given-names>A</given-names> </author><title>TGF-(&#946;) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells</title><source>J Cell Sci</source><year>1999</year><volume>112</volume><issue>Pt 24</issue><fpage>4557</fpage><lpage>4568</lpage>
<author><surname>Lindley</surname> <given-names>LE</given-names> </author><author><surname>Briegel</surname> <given-names>KJ</given-names> </author><title>Molecular characterization of TGF&#946;-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells</title><source>Biochem Biophys Res Commun</source><year>2010</year><volume>399</volume><issue>4</issue><fpage>659</fpage><lpage>664</lpage>
<author><surname>Jo</surname> <given-names>M</given-names> </author><author><surname>Lester</surname> <given-names>RD</given-names> </author><author><surname>Montel</surname> <given-names>V</given-names> </author><title>Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling</title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>34</issue><fpage>22825</fpage><lpage>22833</lpage>
<author><surname>Trimboli</surname> <given-names>AJ</given-names> </author><author><surname>Fukino</surname> <given-names>K</given-names> </author><author><surname>Bruin</surname> <given-names>A</given-names> </author><title>Direct evidence for epithelial-mesenchymal transitions in breast cancer</title><source>Cancer Res</source><year>2008</year><volume>68</volume><issue>3</issue><fpage>937</fpage><lpage>945</lpage>
<author><surname>Turashvili</surname> <given-names>G</given-names> </author><author><surname>Bouchal</surname> <given-names>J</given-names> </author><author><surname>Ehrmann</surname> <given-names>J</given-names> </author><title>Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas</title><source>Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia</source><year>2007</year><volume>151</volume><issue>1</issue><fpage>59</fpage><lpage>64</lpage>
<author><surname>Micalizzi</surname> <given-names>DS</given-names> </author><author><surname>Farabaugh</surname> <given-names>SM</given-names> </author><author><surname>Ford</surname> <given-names>HL</given-names> </author><title>Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression</title><source>J Mammary Gland Biol Neoplasia</source><year>2010</year><volume>15</volume><issue>2</issue><fpage>117</fpage><lpage>134</lpage>
<author><surname>Christofori</surname> <given-names>G</given-names> </author><title>New signals from the invasive front</title><source>Nature</source><year>2006</year><volume>441</volume><issue>7092</issue><fpage>444</fpage><lpage>450</lpage>
<author><surname>Vincent</surname> <given-names>T</given-names> </author><author><surname>Neve</surname> <given-names>EP</given-names> </author><author><surname>Johnson</surname> <given-names>JR</given-names> </author><title>A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-&#946; mediated epithelial-mesenchymal transition</title><source>Nat Cell Biol</source><year>2009</year><volume>11</volume><issue>8</issue><fpage>943</fpage><lpage>950</lpage>
<author><surname>Thuault</surname> <given-names>S</given-names> </author><author><surname>Valcourt</surname> <given-names>U</given-names> </author><author><surname>Petersen</surname> <given-names>M</given-names> </author><title>Transforming growth factor-&#946; employs HMGA2 to elicit epithelial-mesenchymal transition</title><source>J Cell Biol</source><year>2006</year><volume>174</volume><issue>2</issue><fpage>175</fpage><lpage>183</lpage>
<author><surname>Viloria-Petit</surname> <given-names>AM</given-names> </author><author><surname>David</surname> <given-names>L</given-names> </author><author><surname>Jia</surname> <given-names>JY</given-names> </author><title>A role for the TGF&#946;-Par6 polarity pathway in breast cancer progression</title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><issue>33</issue><fpage>14028</fpage><lpage>14033</lpage>
<author><surname>Shirakihara</surname> <given-names>T</given-names> </author><author><surname>Horiguchi</surname> <given-names>K</given-names> </author><author><surname>Miyazawa</surname> <given-names>K</given-names> </author><title>TGF-&#946; regulates isoform switching of FGF receptors and epithelial-mesenchymal transition</title><source>EMBO J</source><year>2011</year><volume>30</volume><issue>4</issue><fpage>783</fpage><lpage>795</lpage>
<author><surname>Wendt</surname> <given-names>MK</given-names> </author><author><surname>Smith</surname> <given-names>JA</given-names> </author><author><surname>Schiemann</surname> <given-names>WP</given-names> </author><title>Transforming growth factor-&#946;-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression</title><source>Oncogene</source><year>2010</year><volume>29</volume><issue>49</issue><fpage>6485</fpage><lpage>6498</lpage>
<author><surname>Micalizzi</surname> <given-names>DS</given-names> </author><author><surname>Christensen</surname> <given-names>KL</given-names> </author><author><surname>Jedlicka</surname> <given-names>P</given-names> </author><title>The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-&#946; signaling</title><source>J Clin Invest</source><year>2009</year><volume>119</volume><issue>9</issue><fpage>2678</fpage><lpage>2690</lpage>
<author><surname>Micalizzi</surname> <given-names>DS</given-names> </author><author><surname>Wang</surname> <given-names>CA</given-names> </author><author><surname>Farabaugh</surname> <given-names>SM</given-names> </author><title>Homeoprotein Six1 increases TGF-&#946; Type I receptor and converts TGF-&#946; signaling from suppressive to supportive for tumor growth</title><source>Cancer Res</source><year>2010</year><volume>70</volume><issue>24</issue><fpage>10371</fpage><lpage>10380</lpage>
<author><surname>Deckers</surname> <given-names>M</given-names> </author><author><surname>Dinther</surname> <given-names>M</given-names> </author><author><surname>Buijs</surname> <given-names>J</given-names> </author><title>The tumor suppressor Smad4 is required for transforming growth factor &#946;-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells</title><source>Cancer Res</source><year>2006</year><volume>66</volume><issue>4</issue><fpage>2202</fpage><lpage>2209</lpage>
<author><surname>Thuault</surname> <given-names>S</given-names> </author><author><surname>Tan</surname> <given-names>EJ</given-names> </author><author><surname>Peinado</surname> <given-names>H</given-names> </author><title>HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition</title><source>J Biol Chem</source><year>2008</year><volume>283</volume><issue>48</issue><fpage>33437</fpage><lpage>33446</lpage>
<author><surname>Gregory</surname> <given-names>PA</given-names> </author><author><surname>Bert</surname> <given-names>AG</given-names> </author><author><surname>Paterson</surname> <given-names>EL</given-names> </author><title>The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1</title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><issue>5</issue><fpage>593</fpage><lpage>601</lpage>
<author><surname>Bakin</surname> <given-names>AV</given-names> </author><author><surname>Tomlinson</surname> <given-names>AK</given-names> </author><author><surname>Bhowmick</surname> <given-names>NA</given-names> </author><title>Phosphatidylinositol 3-kinase function is required for transforming growth factor &#946;-mediated epithelial to mesenchymal transition and cell migration</title><source>J Biol Chem</source><year>2000</year><volume>275</volume><issue>47</issue><fpage>36803</fpage><lpage>36810</lpage>
<author><surname>Graauw</surname> <given-names>M</given-names> </author><author><surname>Miltenburg</surname> <given-names>MH</given-names> </author><author><surname>Schmidt</surname> <given-names>MK</given-names> </author><title>Annexin A1 regulates TGF-&#946; signaling and promotes metastasis formation of basal-like breast cancer cells</title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><issue>14</issue><fpage>6340</fpage><lpage>6345</lpage>
<author><surname>Araki</surname> <given-names>S</given-names> </author><author><surname>Eitel</surname> <given-names>JA</given-names> </author><author><surname>Batuello</surname> <given-names>CN</given-names> </author><title>TGF-&#946;1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer</title><source>J Clin Investig</source><year>2010</year><volume>120</volume><issue>1</issue><fpage>290</fpage><lpage>302</lpage>
<author><surname>Mareel</surname> <given-names>M</given-names> </author><author><surname>Oliveira</surname> <given-names>MJ</given-names> </author><author><surname>Madani</surname> <given-names>I</given-names> </author><title>Cancer invasion and metastasis: interacting ecosystems</title><source>Virchows Archiv: An International Journal of Pathology</source><year>2009</year><volume>454</volume><issue>6</issue><fpage>599</fpage><lpage>622</lpage>
<author><surname>Mareel</surname> <given-names>M</given-names> </author><author><surname>Leroy</surname> <given-names>A</given-names> </author><title>Clinical, cellular, and molecular aspects of cancer invasion</title><source>Physiol Rev</source><year>2003</year><volume>83</volume><issue>2</issue><fpage>337</fpage><lpage>376</lpage>
<author><surname>Hu</surname> <given-names>M</given-names> </author><author><surname>Yao</surname> <given-names>J</given-names> </author><author><surname>Carroll</surname> <given-names>DK</given-names> </author><title>Regulation of in situ to invasive breast carcinoma transition</title><source>Cancer Cell</source><year>2008</year><volume>13</volume><issue>5</issue><fpage>394</fpage><lpage>406</lpage>
<author><surname>Luo</surname> <given-names>YP</given-names> </author><author><surname>Zhou</surname> <given-names>H</given-names> </author><author><surname>Krueger</surname> <given-names>J</given-names> </author><title>The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression</title><source>Oncogene</source><year>2010</year><volume>29</volume><issue>5</issue><fpage>662</fpage><lpage>673</lpage>
<author><surname>Mandal</surname> <given-names>S</given-names> </author><author><surname>Johnson</surname> <given-names>KR</given-names> </author><author><surname>Wheelock</surname> <given-names>MJ</given-names> </author><title>TGF-&#946; induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways</title><source>Exp Cell Res</source><year>2008</year><volume>314</volume><issue>19</issue><fpage>3478</fpage><lpage>3493</lpage>
<author><surname>Giampieri</surname> <given-names>S</given-names> </author><author><surname>Manning</surname> <given-names>C</given-names> </author><author><surname>Hooper</surname> <given-names>S</given-names> </author><title>Localized and reversible TGF-&#946; signalling switches breast cancer cells from cohesive to single cell motility</title><source>Nat Cell Biol</source><year>2009</year><volume>11</volume><issue>11</issue><fpage>1287</fpage><lpage>1296</lpage>
<author><surname>McAllister</surname> <given-names>SS</given-names> </author><author><surname>Weinberg</surname> <given-names>RA</given-names> </author><title>Tumor-host interactions: a far-reaching relationship</title><source>J Clin Oncol: Official Journal of the American Society of Clinical Oncology</source><year>2010</year><volume>28</volume><issue>26</issue><fpage>4022</fpage><lpage>4028</lpage>
<author><surname>Park</surname> <given-names>CC</given-names> </author><author><surname>Bissell</surname> <given-names>MJ</given-names> </author><author><surname>Barcellos-Hoff</surname> <given-names>MH</given-names> </author><title>The influence of the microenvironment on the malignant phenotype</title><source>Mol Med Today</source><year>2000</year><volume>6</volume><issue>8</issue><fpage>324</fpage><lpage>329</lpage>
<author><surname>Mueller</surname> <given-names>MM</given-names> </author><author><surname>Fusenig</surname> <given-names>NE</given-names> </author><title>Friends or foes - bipolar effects of the tumour stroma in cancer</title><source>Nat Rev Cancer</source><year>2004</year><volume>4</volume><issue>11</issue><fpage>839</fpage><lpage>849</lpage>
<author><surname>Sieweke</surname> <given-names>MH</given-names> </author><author><surname>Bissell</surname> <given-names>MJ</given-names> </author><title>The tumor-promoting effect of wounding: a possible role for TGF-&#946;-induced stromal alterations</title><source>Crit Rev Oncog</source><year>1994</year><volume>5</volume><issue>2&#8211;3</issue><fpage>297</fpage><lpage>311</lpage>
<author><surname>Shekhar</surname> <given-names>MP</given-names> </author><author><surname>Pauley</surname> <given-names>R</given-names> </author><author><surname>Heppner</surname> <given-names>G</given-names> </author><title>Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast</title><source>Breast Cancer Res</source><year>2003</year><volume>5</volume><issue>3</issue><fpage>130</fpage><lpage>135</lpage>
<author><surname>Olsen</surname> <given-names>CJ</given-names> </author><author><surname>Moreira</surname> <given-names>J</given-names> </author><author><surname>Lukanidin</surname> <given-names>EM</given-names> </author><title>Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts</title><source>BMC Cancer</source><year>2010</year><volume>10</volume><fpage>444</fpage>
<author><surname>Stuelten</surname> <given-names>CH</given-names> </author><author><surname>Busch</surname> <given-names>JI</given-names> </author><author><surname>Tang</surname> <given-names>B</given-names> </author><title>Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-&#946; mediated mechanism in a mouse xenograft model of breast cancer</title><source>PLoS ONE</source><year>2010</year><volume>5</volume><issue>3</issue><fpage>e9832</fpage>
<author><surname>Karnoub</surname> <given-names>AE</given-names> </author><author><surname>Dash</surname> <given-names>AB</given-names> </author><author><surname>Vo</surname> <given-names>AP</given-names> </author><title>Mesenchymal stem cells within tumour stroma promote breast cancer metastasis</title><source>Nature</source><year>2007</year><volume>449</volume><issue>7162</issue><fpage>557</fpage><lpage>563</lpage>
<author><surname>Haviv</surname> <given-names>I</given-names> </author><author><surname>Polyak</surname> <given-names>K</given-names> </author><author><surname>Qiu</surname> <given-names>W</given-names> </author><title>Origin of carcinoma associated fibroblasts</title><source>Cell Cycle</source><year>2009</year><volume>8</volume><issue>4</issue><fpage>589</fpage><lpage>595</lpage>
<author><surname>Kojima</surname> <given-names>Y</given-names> </author><author><surname>Acar</surname> <given-names>A</given-names> </author><author><surname>Eaton</surname> <given-names>EN</given-names> </author><title>Autocrine TGF-&#946; and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts</title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><issue>46</issue><fpage>20009</fpage><lpage>20014</lpage>
<author><surname>Bhowmick</surname> <given-names>NA</given-names> </author><author><surname>Chytil</surname> <given-names>A</given-names> </author><author><surname>Plieth</surname> <given-names>D</given-names> </author><title>TGF-&#946; signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia</title><source>Science</source><year>2004</year><volume>303</volume><issue>5659</issue><fpage>848</fpage><lpage>851</lpage>
<author><surname>Cheng</surname> <given-names>N</given-names> </author><author><surname>Bhowmick</surname> <given-names>NA</given-names> </author><author><surname>Chytil</surname> <given-names>A</given-names> </author><title>Loss of TGF-&#946; type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-&#945;-, MSP- and HGF-mediated signaling networks</title><source>Oncogene</source><year>2005</year><volume>24</volume><issue>32</issue><fpage>5053</fpage><lpage>5068</lpage>
<author><surname>Cheng</surname> <given-names>N</given-names> </author><author><surname>Chytil</surname> <given-names>A</given-names> </author><author><surname>Shyr</surname> <given-names>Y</given-names> </author><title>Transforming growth factor-&#946; signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion</title><source>Molec Cancer Res</source><year>2008</year><volume>6</volume><issue>10</issue><fpage>1521</fpage><lpage>1533</lpage>
<author><surname>Barcellos-Hoff</surname> <given-names>MH</given-names> </author><author><surname>Ravani</surname> <given-names>SA</given-names> </author><title>Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells</title><source>Cancer Res</source><year>2000</year><volume>60</volume><issue>5</issue><fpage>1254</fpage><lpage>1260</lpage>
<author><surname>Barcellos-Hoff</surname> <given-names>MH</given-names> </author><title>Radiation-induced transforming growth factor &#946; and subsequent extracellular matrix reorganization in murine mammary gland</title><source>Cancer Res</source><year>1993</year><volume>53</volume><issue>17</issue><fpage>3880</fpage><lpage>3886</lpage>
<author><surname>Casey</surname> <given-names>TM</given-names> </author><author><surname>Eneman</surname> <given-names>J</given-names> </author><author><surname>Crocker</surname> <given-names>A</given-names> </author><title>Cancer associated fibroblasts stimulated by transforming growth factor &#946;1 (TGF-&#946;1) increase invasion rate of tumor cells: a population study</title><source>Breast Cancer Res Treat</source><year>2008</year><volume>110</volume><issue>1</issue><fpage>39</fpage><lpage>49</lpage>
<author><surname>Mantovani</surname> <given-names>A</given-names> </author><author><surname>Marchesi</surname> <given-names>F</given-names> </author><author><surname>Porta</surname> <given-names>C</given-names> </author><title>Inflammation and cancer: breast cancer as a prototype</title><source>Breast</source><year>2007</year><volume>16</volume><issue>Suppl 2</issue><fpage>S27</fpage><lpage>S33</lpage>
<author><surname>Bierie</surname> <given-names>B</given-names> </author><author><surname>Moses</surname> <given-names>HL</given-names> </author><title>TGF-&#946; and cancer</title><source>Cytokine Growth Factor Rev</source><year>2006</year><volume>17</volume><issue>1&#8211;2</issue><fpage>29</fpage><lpage>40</lpage>
<author><surname>Marigo</surname> <given-names>I</given-names> </author><author><surname>Dolcetti</surname> <given-names>L</given-names> </author><author><surname>Serafini</surname> <given-names>P</given-names> </author><title>Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells</title><source>Immunol Rev</source><year>2008</year><volume>222</volume><fpage>162</fpage><lpage>179</lpage>
<author><surname>Gallina</surname> <given-names>G</given-names> </author><author><surname>Dolcetti</surname> <given-names>L</given-names> </author><author><surname>Serafini</surname> <given-names>P</given-names> </author><title>Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells</title><source>J Clin Investig</source><year>2006</year><volume>116</volume><issue>10</issue><fpage>2777</fpage><lpage>2790</lpage>
<author><surname>Yang</surname> <given-names>L</given-names> </author><author><surname>Huang</surname> <given-names>J</given-names> </author><author><surname>Ren</surname> <given-names>X</given-names> </author><title>Abrogation of TGF-&#946; signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis</title><source>Cancer Cell</source><year>2008</year><volume>13</volume><issue>1</issue><fpage>23</fpage><lpage>35</lpage>
<author><surname>Oliveira</surname> <given-names>MJ</given-names> </author><author><surname>Damme</surname> <given-names>J</given-names> </author><author><surname>Lauwaet</surname> <given-names>T</given-names> </author><title>&#946;-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motility</title><source>EMBO J</source><year>2003</year><volume>22</volume><issue>22</issue><fpage>6161</fpage><lpage>6173</lpage>
<author><surname>Leask</surname> <given-names>A</given-names> </author><author><surname>Abraham</surname> <given-names>DJ</given-names> </author><title>TGF-&#946; signaling and the fibrotic response</title><source>FASEB J: Official Publication of the Federation of American Societies for Experimental Biology</source><year>2004</year><volume>18</volume><issue>7</issue><fpage>816</fpage><lpage>827</lpage>
<author><surname>Kang</surname> <given-names>Y</given-names> </author><author><surname>He</surname> <given-names>W</given-names> </author><author><surname>Tulley</surname> <given-names>S</given-names> </author><title>Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway</title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><issue>39</issue><fpage>13909</fpage><lpage>13914</lpage>
<author><surname>Alarmo</surname> <given-names>EL</given-names> </author><author><surname>Parssinen</surname> <given-names>J</given-names> </author><author><surname>Ketolainen</surname> <given-names>JM</given-names> </author><title>BMP7 influences proliferation, migration, and invasion of breast cancer cells</title><source>Cancer Lett</source><year>2009</year><volume>275</volume><issue>1</issue><fpage>35</fpage><lpage>43</lpage>
<author><surname>Ketolainen</surname> <given-names>JM</given-names> </author><author><surname>Alarmo</surname> <given-names>EL</given-names> </author><author><surname>Tuominen</surname> <given-names>VJ</given-names> </author><title>Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4</title><source>Breast Cancer Res Treat</source><year>2010</year><volume>124</volume><issue>2</issue><fpage>377</fpage><lpage>386</lpage>
<author><surname>Alarmo</surname> <given-names>EL</given-names> </author><author><surname>Korhonen</surname> <given-names>T</given-names> </author><author><surname>Kuukasjarvi</surname> <given-names>T</given-names> </author><title>Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas</title><source>Ann Oncol: Official Journal of the European Society for Medical Oncology/ESMO</source><year>2008</year><volume>19</volume><issue>2</issue><fpage>308</fpage><lpage>314</lpage>
<author><surname>Blair</surname> <given-names>HC</given-names> </author><author><surname>Athanasou</surname> <given-names>NA</given-names> </author><title>Recent advances in osteoclast biology and pathological bone resorption</title><source>Histol Histopathol</source><year>2004</year><volume>19</volume><issue>1</issue><fpage>189</fpage><lpage>199</lpage>
<author><surname>Henderson</surname> <given-names>MA</given-names> </author><author><surname>Danks</surname> <given-names>JA</given-names> </author><author><surname>Slavin</surname> <given-names>JL</given-names> </author><title>Parathyroid hormone-related protein localization in breast cancers predict improved prognosis</title><source>Cancer Res</source><year>2006</year><volume>66</volume><issue>4</issue><fpage>2250</fpage><lpage>2256</lpage>
<author><surname>Powell</surname> <given-names>GJ</given-names> </author><author><surname>Southby</surname> <given-names>J</given-names> </author><author><surname>Danks</surname> <given-names>JA</given-names> </author><title>Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites</title><source>Cancer Res</source><year>1991</year><volume>51</volume><issue>11</issue><fpage>3059</fpage><lpage>3061</lpage>
<author><surname>Guise</surname> <given-names>TA</given-names> </author><author><surname>Yin</surname> <given-names>JJ</given-names> </author><author><surname>Taylor</surname> <given-names>SD</given-names> </author><title>Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis</title><source>J Clin Investig</source><year>1996</year><volume>98</volume><issue>7</issue><fpage>1544</fpage><lpage>1549</lpage>
<author><surname>Yin</surname> <given-names>JJ</given-names> </author><author><surname>Selander</surname> <given-names>K</given-names> </author><author><surname>Chirgwin</surname> <given-names>JM</given-names> </author><title>TGF-&#946; signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development</title><source>J Clin Invest</source><year>1999</year><volume>103</volume><issue>2</issue><fpage>197</fpage><lpage>206</lpage>
<author><surname>Kakonen</surname> <given-names>SM</given-names> </author><author><surname>Selander</surname> <given-names>KS</given-names> </author><author><surname>Chirgwin</surname> <given-names>JM</given-names> </author><title>Transforming growth factor-&#946; stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways</title><source>J Biol Chem</source><year>2002</year><volume>277</volume><issue>27</issue><fpage>24571</fpage><lpage>24578</lpage>
<author><surname>Evtimova</surname> <given-names>V</given-names> </author><author><surname>Schwirzke</surname> <given-names>M</given-names> </author><author><surname>Tarbe</surname> <given-names>N</given-names> </author><title>Identification of breast cancer metastasis-associated genes by chip technology</title><source>Anticancer Res</source><year>2001</year><volume>21</volume><issue>6A</issue><fpage>3799</fpage><lpage>3806</lpage>
<author><surname>Watson</surname> <given-names>MA</given-names> </author><author><surname>Ylagan</surname> <given-names>LR</given-names> </author><author><surname>Trinkaus</surname> <given-names>KM</given-names> </author><title>Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients</title><source>Clin Cancer Res: An Official Journal of the American Association for Cancer Research</source><year>2007</year><volume>13</volume><issue>17</issue><fpage>5001</fpage><lpage>5009</lpage>
<author><surname>Lu</surname> <given-names>X</given-names> </author><author><surname>Wang</surname> <given-names>Q</given-names> </author><author><surname>Hu</surname> <given-names>G</given-names> </author><title>ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis</title><source>Genes Dev</source><year>2009</year><volume>23</volume><issue>16</issue><fpage>1882</fpage><lpage>1894</lpage>
<author><surname>Kang</surname> <given-names>Y</given-names> </author><author><surname>Massagu&#233;</surname> <given-names>J</given-names> </author><title>Epithelial-mesenchymal transitions: twist in development and metastasis</title><source>Cell</source><year>2004</year><volume>118</volume><issue>3</issue><fpage>277</fpage><lpage>279</lpage>
<author><surname>Dunn</surname> <given-names>LK</given-names> </author><author><surname>Mohammad</surname> <given-names>KS</given-names> </author><author><surname>Fournier</surname> <given-names>PG</given-names> </author><title>Hypoxia and TGF-&#946; drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment</title><source>PLoS ONE</source><year>2009</year><volume>4</volume><issue>9</issue><fpage>e6896</fpage>
<author><surname>Katoh</surname> <given-names>M</given-names> </author><title>Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGF&#946;, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors</title><source>Int J Oncol</source><year>2010</year><volume>36</volume><issue>2</issue><fpage>415</fpage><lpage>420</lpage>
<author><surname>Shimo</surname> <given-names>T</given-names> </author><author><surname>Kubota</surname> <given-names>S</given-names> </author><author><surname>Yoshioka</surname> <given-names>N</given-names> </author><title>Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer</title><source>J Bone Miner Res: The Official Journal of the American Society for Bone and Mineral Research</source><year>2006</year><volume>21</volume><issue>7</issue><fpage>1045</fpage><lpage>1059</lpage>
<author><surname>Alarmo</surname> <given-names>EL</given-names> </author><author><surname>Kallioniemi</surname> <given-names>A</given-names> </author><title>Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?</title><source>Endocr-Relat Cancer</source><year>2010</year><volume>17</volume><issue>2</issue><fpage>R123</fpage><lpage>R139</lpage>
<author><surname>Johnson</surname> <given-names>RW</given-names> </author><author><surname>Nguyen</surname> <given-names>MP</given-names> </author><author><surname>Padalecki</surname> <given-names>SS</given-names> </author><title>TGF-&#946; promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical hedgehog signaling</title><source>Cancer Res</source><year>2011</year><volume>71</volume><issue>3</issue><fpage>822</fpage><lpage>831</lpage>
<author><surname>Futakuchi</surname> <given-names>M</given-names> </author><author><surname>Nannuru</surname> <given-names>KC</given-names> </author><author><surname>Varney</surname> <given-names>ML</given-names> </author><title>Transforming growth factor-&#946; signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation</title><source>Cancer Sci</source><year>2009</year><volume>100</volume><issue>1</issue><fpage>71</fpage><lpage>81</lpage>
<author><surname>Bierie</surname> <given-names>B</given-names> </author><author><surname>Stover</surname> <given-names>DG</given-names> </author><author><surname>Abel</surname> <given-names>TW</given-names> </author><title>Transforming growth factor-&#946; regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment</title><source>Cancer Res</source><year>2008</year><volume>68</volume><issue>6</issue><fpage>1809</fpage><lpage>1819</lpage>
<author><surname>Korpal</surname> <given-names>M</given-names> </author><author><surname>Yan</surname> <given-names>J</given-names> </author><author><surname>Lu</surname> <given-names>X</given-names> </author><title>Imaging transforming growth factor-&#946; signaling dynamics and therapeutic response in breast cancer bone metastasis</title><source>Nat Med</source><year>2009</year><volume>15</volume><issue>8</issue><fpage>960</fpage><lpage>966</lpage>
<author><surname>Petersen</surname> <given-names>M</given-names> </author><author><surname>Pardali</surname> <given-names>E</given-names> </author><author><surname>Horst</surname> <given-names>G</given-names> </author><title>Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis</title><source>Oncogene</source><year>2010</year><volume>29</volume><issue>9</issue><fpage>1351</fpage><lpage>1361</lpage>
<author><surname>Buijs</surname> <given-names>JT</given-names> </author><author><surname>Que</surname> <given-names>I</given-names> </author><author><surname>Lowik</surname> <given-names>CW</given-names> </author><title>Inhibition of bone resorption and growth of breast cancer in the bone microenvironment</title><source>Bone</source><year>2009</year><volume>44</volume><issue>2</issue><fpage>380</fpage><lpage>386</lpage>
<author><surname>Buijs</surname> <given-names>JT</given-names> </author><author><surname>Henriquez</surname> <given-names>NV</given-names> </author><author><surname>Overveld</surname> <given-names>PG</given-names> </author><title>TGF-&#946; and BMP7 interactions in tumour progression and bone metastasis</title><source>Clin Exp Metastasis</source><year>2007</year><volume>24</volume><issue>8</issue><fpage>609</fpage><lpage>617</lpage>
<author><surname>Buijs</surname> <given-names>JT</given-names> </author><author><surname>Kuijpers</surname> <given-names>CC</given-names> </author><author><surname>Pluijm</surname> <given-names>G</given-names> </author><title>Targeted therapy options for treatment of bone metastases; beyond bisphosphonates</title><source>Curr Pharm Des</source><year>2010</year><volume>16</volume><issue>27</issue><fpage>3015</fpage><lpage>3027</lpage>
<author><surname>Buijs</surname> <given-names>JT</given-names> </author><author><surname>Petersen</surname> <given-names>M</given-names> </author><author><surname>Horst</surname> <given-names>G</given-names> </author><title>Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis?</title><source>Curr Pharm Des</source><year>2010</year><volume>16</volume><issue>11</issue><fpage>1291</fpage><lpage>1300</lpage>
<author><surname>Kingsley</surname> <given-names>LA</given-names> </author><author><surname>Fournier</surname> <given-names>PG</given-names> </author><author><surname>Chirgwin</surname> <given-names>JM</given-names> </author><title>Molecular biology of bone metastasis</title><source>Mol Cancer Ther</source><year>2007</year><volume>6</volume><issue>10</issue><fpage>2609</fpage><lpage>2617</lpage>
<author><surname>McMahon</surname> <given-names>S</given-names> </author><author><surname>Charbonneau</surname> <given-names>M</given-names> </author><author><surname>Grandmont</surname> <given-names>S</given-names> </author><title>Transforming growth factor &#946;1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression</title><source>J Biol Chem</source><year>2006</year><volume>281</volume><issue>34</issue><fpage>24171</fpage><lpage>24181</lpage>
<author><surname>Pluijm</surname> <given-names>G</given-names> </author><author><surname>Sijmons</surname> <given-names>B</given-names> </author><author><surname>Vloedgraven</surname> <given-names>H</given-names> </author><title>Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases</title><source>J Bone Miner Res: The Official Journal of the American Society for Bone and Mineral Research</source><year>2001</year><volume>16</volume><issue>6</issue><fpage>1077</fpage><lpage>1091</lpage>
<author><surname>Davies</surname> <given-names>S</given-names> </author><author><surname>Jiang</surname> <given-names>WG</given-names> </author><title>ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis</title><source>Anticancer Res</source><year>2010</year><volume>30</volume><issue>4</issue><fpage>1163</fpage><lpage>1168</lpage>
<author><surname>Galaup</surname> <given-names>A</given-names> </author><author><surname>Cazes</surname> <given-names>A</given-names> </author><author><surname>Jan</surname> <given-names>S</given-names> </author><title>Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness</title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><issue>49</issue><fpage>18721</fpage><lpage>18726</lpage>
<author><surname>Gupta</surname> <given-names>GP</given-names> </author><author><surname>Perk</surname> <given-names>J</given-names> </author><author><surname>Acharyya</surname> <given-names>S</given-names> </author><title>ID genes mediate tumor reinitiation during breast cancer lung metastasis</title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><issue>49</issue><fpage>19506</fpage><lpage>19511</lpage>
<author><surname>Sadej</surname> <given-names>R</given-names> </author><author><surname>Romanska</surname> <given-names>H</given-names> </author><author><surname>Kavanagh</surname> <given-names>D</given-names> </author><title>Tetraspanin CD151 regulates transforming growth factor &#946; signaling: implication in tumor metastasis</title><source>Cancer Res</source><year>2010</year><volume>70</volume><issue>14</issue><fpage>6059</fpage><lpage>6070</lpage>